Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIK066 Glucose Absorption in T2DM
NCT01915849Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of licogliflozin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Novartis. Primary endpoint: Area Under the Postprandial Curve for Rate of Appearance of Exogenous Glucose at Day 4. Started Jul 2013; status: completed.
02
Drugs
licogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01915849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915849.